Annual Total Long Term Liabilities
$6.01 M
-$111.93 M-94.91%
31 December 2023
Summary:
Elicio Therapeutics annual total long term liabilities is currently $6.01 million, with the most recent change of -$111.93 million (-94.91%) on 31 December 2023. During the last 3 years, it has fallen by -$59.49 million (-90.83%). ELTX annual total long term liabilities is now -94.91% below its all-time high of $117.94 million, reached on 31 December 2022.ELTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$48.35 M
+$38.54 M+392.55%
30 September 2024
Summary:
Elicio Therapeutics quarterly total long term liabilities is currently $48.35 million, with the most recent change of +$38.54 million (+392.55%) on 30 September 2024. Over the past year, it has increased by +$42.14 million (+678.02%). ELTX quarterly long term liabilities is now -59.00% below its all-time high of $117.94 million, reached on 31 December 2022.ELTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELTX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.9% | +678.0% |
| 3 y3 years | -90.8% | -31.4% |
| 5 y5 years | - | - |
ELTX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -94.9% | at low | -59.0% | +705.0% |
| 5 y | 5 years | -94.9% | at low | -59.0% | +705.0% |
| alltime | all time | -94.9% | at low | -59.0% | +705.0% |
Elicio Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.35 M(+392.6%) |
| June 2024 | - | $9.82 M(-28.1%) |
| Mar 2024 | - | $13.66 M(+127.4%) |
| Dec 2023 | $6.01 M | $6.01 M(-3.3%) |
| Sept 2023 | - | $6.21 M(-3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $6.46 M(-94.5%) |
| Dec 2022 | $117.94 M(+67.4%) | $117.94 M(+67.3%) |
| Dec 2021 | $70.47 M(+7.6%) | - |
| Mar 2021 | - | $70.49 M |
| Dec 2020 | $65.49 M(+56.0%) | - |
| Dec 2019 | $41.99 M | - |
FAQ
- What is Elicio Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Elicio Therapeutics?
- What is Elicio Therapeutics annual total long term liabilities year-on-year change?
- What is Elicio Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly long term liabilities year-on-year change?
What is Elicio Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ELTX is $6.01 M
What is the all time high annual total long term liabilities for Elicio Therapeutics?
Elicio Therapeutics all-time high annual total long term liabilities is $117.94 M
What is Elicio Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ELTX annual total long term liabilities has changed by -$111.93 M (-94.91%)
What is Elicio Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ELTX is $48.35 M
What is the all time high quarterly long term liabilities for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly total long term liabilities is $117.94 M
What is Elicio Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ELTX quarterly total long term liabilities has changed by +$42.14 M (+678.02%)